| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.055 | 0.3 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.3 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.3 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.085 | 0.3 |